IPD 1.79% 5.5¢ impedimed limited

Ann: US FDA 510(k) Clearance for Bilateral Lymphoedema Assessment, page-2

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 5,440 Posts.
    lightbulb Created with Sketch. 1282
    Yay! .. read this article the other day ... now that we've had 3 in under 12 months I think we'd fall into this category?

    The road to FDA clearance for medical devices may change radically in the next year.
    Last summer, initial discussion began around implementing a pre-certification program for medical device companies, which would allow certain companies that the FDA has deemed responsible and safe in their development to build products without each new device undergoing the FDA clearance or approval process.


    http://www.mobihealthnews.com/conte...orkshops-give-industry-and-agency-chance-talk

    “This, our third 510(k) clearance in under 12 months for the SOZO® platform, follows our recent clearance for monitoring fluid levels in heart failure patients, achieving yet another important regulatory milestone in our journey of providing a new and improved model of care, across the patient care continuum.”
 
watchlist Created with Sketch. Add IPD (ASX) to my watchlist
(20min delay)
Last
5.5¢
Change
-0.001(1.79%)
Mkt cap ! $111.2M
Open High Low Value Volume
5.7¢ 5.7¢ 5.4¢ $43.81K 805.0K

Buyers (Bids)

No. Vol. Price($)
2 150000 5.2¢
 

Sellers (Offers)

Price($) Vol. No.
5.5¢ 333033 2
View Market Depth
Last trade - 16.10pm 12/11/2024 (20 minute delay) ?
IPD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.